0,874  0,004  Lipoxygenase inhibitor
0,869  0,002  Monophenol monooxygenase inhibitor
0,871  0,004  15-Lipoxygenase inhibitor
0,868  0,003  Skin whitener
0,834  0,002  Melanin inhibitor
0,833  0,003  NOS2 expression inhibitor
0,811  0,004  12-Lipoxygenase inhibitor
0,774  0,020  Apoptosis agonist
0,772  0,019  Antiinflammatory
0,758  0,012  Antineoplastic (lung cancer)
0,739  0,005  Antioxidant
0,742  0,008  Chemopreventive
0,734  0,017  Transcription factor NF kappa B inhibitor
0,730  0,016  Antineoplastic (breast cancer)
0,716  0,009  Antihypercholesterolemic
0,692  0,007  UGT1A9 substrate
0,695  0,010  Radioprotector
0,667  0,010  Sensitization
0,658  0,006  Cardioprotectant
0,651  0,007  AR expression inhibitor
0,644  0,006  Free radical scavenger
0,643  0,009  Cardiovascular analeptic
0,626  0,009  Antiosteoporotic
0,618  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,619  0,012  Bone diseases treatment
0,604  0,008  UGT1A6 substrate
0,585  0,013  Proliferative diseases treatment
0,578  0,013  Cytostatic
0,580  0,020  Prostate cancer treatment
0,563  0,006  Antihypertriglyceridemic
0,553  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,559  0,013  Caspase 3 stimulant
0,554  0,013  Antineoplastic (brain cancer)
0,545  0,004  Protein-tyrosine phosphatase inhibitor
0,546  0,013  Nitric oxide antagonist
0,559  0,027  Antibacterial
0,545  0,014  Antiparasitic
0,548  0,020  CYP2C19 substrate
0,526  0,009  UGT1A1 substrate
0,535  0,019  Histamine release inhibitor
0,521  0,006  UGT1A3 substrate
0,524  0,010  Vasodilator
0,526  0,013  CYP1A2 inhibitor
0,512  0,006  Antineoplastic (squamous cell carcinoma)
0,517  0,016  Antineoplastic (glioma)
0,520  0,020  Antineoplastic (cervical cancer)
0,536  0,038  TNF expression inhibitor
0,539  0,047  Caspase 9 stimulant
0,507  0,019  NOS3 expression inhibitor
0,522  0,036  Antileukemic
0,512  0,030  Immunosuppressant
0,491  0,011  Myocardial infarction treatment
0,484  0,009  UGT1A4 substrate
0,481  0,008  Genotoxic
0,471  0,013  UDP-glucuronosyltransferase substrate
0,475  0,025  Chemoprotective
0,462  0,012  Antihelmintic
0,479  0,029  CYP2C19 inhibitor
0,466  0,017  Superoxide dismutase inhibitor
0,521  0,074  Alpha-glucosidase inhibitor
0,473  0,027  Hepatic disorders treatment
0,480  0,039  Antipruritic, allergic
0,451  0,023  ICAM1 expression inhibitor
0,459  0,035  Ulceration
0,431  0,009  Antihypotensive
0,441  0,024  Antiprotozoal (Leishmania)
0,443  0,025  Antineoplastic (multiple myeloma)
0,434  0,023  Hypoglycemic
0,439  0,028  Carcinogenic
0,405  0,003  Gastritis treatment
0,409  0,009  Lipid peroxidase inhibitor
0,404  0,005  5-Lipoxygenase inhibitor
0,436  0,038  Respiratory analeptic
0,399  0,002  Ornithine decarboxylase inhibitor
0,430  0,035  Antineoplastic (melanoma)
0,430  0,037  Antifungal
0,431  0,047  Antineoplastic (colorectal cancer)
0,449  0,067  Antidiabetic
0,449  0,067  Cyclophilin D inhibitor
0,425  0,045  Antineoplastic (colon cancer)
0,418  0,040  Antineoplastic (ovarian cancer)
0,391  0,013  Antineoplastic (carcinoma)
0,383  0,009  NOS3 expression enhancer
0,377  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,414  0,043  Streptokinase A inhibitor
0,371  0,004  Electron transport complex I inhibitor
0,438  0,074  Alzheimer's disease treatment
0,377  0,015  Hepatoprotectant
0,366  0,005  Antihemorrhagic
0,358  0,005  Heat shock protein 90 antagonist
0,355  0,004  Postmenopausal disorders treatment
0,375  0,029  Antineoplastic (renal cancer)
0,349  0,004  Aromatase inhibitor
0,376  0,032  Antineoplastic (glioblastoma multiforme)
0,356  0,013  Topoisomerase II inhibitor
0,367  0,034  Antihypoxic
0,375  0,044  Antineoplastic (pancreatic cancer)
0,348  0,020  Antimutagenic
0,376  0,049  CYP2D6 substrate
0,327  0,006  Topoisomerase II alpha inhibitor
0,314  0,004  MAP kinase kinase 4 inhibitor
0,356  0,048  CTGF expression inhibitor
0,356  0,053  Apoptosis antagonist
0,315  0,014  Neurotrophic factor enhancer
0,314  0,016  Amylase inhibitor
0,350  0,053  Lipoprotein disorders treatment
0,337  0,046  Antineoplastic (osteosarcoma)
0,295  0,006  Beta glucuronidase inhibitor
0,310  0,027  P-glycoprotein inhibitor
0,287  0,005  Estrogen receptor alpha antagonist
0,329  0,050  UGT2B4 substrate
0,335  0,057  Analeptic
0,311  0,040  Antiulcerative
0,330  0,059  Spasmolytic
0,315  0,049  Cytotoxic
0,285  0,023  CYP2B6 inhibitor
0,342  0,081  CYP3A4 substrate
0,307  0,046  Vascular (periferal) disease treatment
0,287  0,030  VCAM1 expression inhibitor
0,276  0,021  UGT2B15 substrate
0,275  0,024  MAO inhibitor
0,257  0,006  Estrogen receptor beta antagonist
0,337  0,086  CYP2C9 substrate
0,311  0,063  CYP1A2 substrate
0,255  0,011  Antibacterial (Helicobacter pylori)
0,296  0,053  Antidiabetic symptomatic
0,249  0,009  Estrogen antagonist
0,311  0,072  Antimycobacterial
0,297  0,058  Antineoplastic (non-small cell lung cancer)
0,241  0,005  Lipase inhibitor
0,272  0,035  Non-steroidal antiinflammatory agent
0,330  0,094  CYP2C9 inhibitor
0,268  0,035  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,252  0,020  Antineoplastic (bone cancer)
0,329  0,098  GABA C receptor rho-3 antagonist
0,292  0,064  Teratogen
0,242  0,016  Cystathionine beta-synthase inhibitor
0,245  0,022  UGT2B9 substrate
0,327  0,105  Antiprotozoal
0,265  0,045  Platelet adhesion inhibitor
0,266  0,047  Antineoplastic enhancer
0,221  0,004  Ca(v)3.1 blocker
0,297  0,082  Sodium/bile acid cotransporter inhibitor
0,278  0,065  Embryotoxic
0,274  0,062  Antineoplastic (liver cancer)
0,277  0,067  GST M1-1 substrate
0,228  0,021  SULT1A3 substrate
0,294  0,092  Antithrombotic
0,214  0,012  Androgen antagonist
0,254  0,053  Mutagenic
0,209  0,008  Estrogen agonist
0,230  0,030  Succinate dehydrogenase inhibitor
0,217  0,019  Arachidonic acid antagonist
0,227  0,031  Phospholipase A2 inhibitor
0,259  0,064  Antiglaucomic
0,222  0,027  Cyclooxygenase 1 inhibitor
0,216  0,023  Topoisomerase I inhibitor
0,245  0,052  RNA-directed DNA polymerase inhibitor
0,216  0,029  Antidiarrheal
0,200  0,014  Breast cancer-resistant protein inhibitor
0,204  0,019  Antifungal (Cryptococcus)
0,223  0,039  Antiviral (Herpes)
0,198  0,014  Dementia treatment
0,261  0,078  Aldehyde oxidase inhibitor
0,250  0,067  Antineoplastic (lymphocytic leukemia)
0,249  0,068  Hypolipemic
0,193  0,013  Vascular dementia treatment
0,204  0,026  Cholesterol synthesis inhibitor
0,253  0,075  Antipyretic
0,208  0,034  Bone formation stimulant
0,259  0,086  Antituberculosic
0,196  0,025  MAO B inhibitor
0,191  0,025  Farnesoid X receptor antagonist
0,170  0,005  Neuraminidase inhibitor
0,185  0,020  Coagulant
0,193  0,031  MAO A inhibitor
0,247  0,084  5 Hydroxytryptamine uptake stimulant
0,272  0,110  Cholesterol antagonist
0,226  0,066  Amyloid beta aggregation inhibitor
0,276  0,116  Antiprotozoal (Plasmodium)
0,179  0,019  Mediator release inhibitor
0,168  0,009  Antiviral (Coronavirus)
0,168  0,009  Antiviral (SARS coronavirus)
0,242  0,085  DNA damaging
0,233  0,079  Antiamyloidogenic
0,179  0,025  Antineoplastic antibiotic
0,210  0,058  UGT2B7 substrate
0,192  0,044  UGT2B10 substrate
0,212  0,064  Pneumotoxic
0,211  0,064  Abortion inducer
0,184  0,038  Acetylcholinesterase inhibitor
0,169  0,027  SULT1A1 substrate
0,144  0,005  Fatty acid synthase inhibitor
0,178  0,039  Neurotrophic factor
0,163  0,031  Chelator
0,187  0,058  Heat shock protein 90 alpha antagonist
0,155  0,027  TRPA1 agonist
0,231  0,104  Gastrin inhibitor
0,168  0,042  Skin irritative effect
0,130  0,005  Ca(v)3.2 blocker
0,260  0,135  GST A substrate
0,175  0,053  Interferon gamma antagonist
0,212  0,092  Antiviral (West Nile virus)
0,188  0,069  Antipruritic, non-allergic
0,129  0,010  Neuraminidase (influenza) inhibitor
0,162  0,043  DNA polymerase I inhibitor
0,292  0,174  5 Hydroxytryptamine release inhibitor
0,218  0,101  Antineoplastic (sarcoma)
0,183  0,070  LDLR expression enhancer
0,135  0,021  SULT1E1 substrate
0,218  0,106  Tyrosine 3 hydroxylase inhibitor
0,200  0,088  Nitric-oxide synthase stimulant
0,121  0,016  Na+ K+ transporting ATPase inhibitor
0,175  0,071  Dual specificity phosphatase inhibitor
0,141  0,038  Xanthine oxidase inhibitor
0,120  0,019  HIV-1 integrase (3'-Processing) inhibitor
0,105  0,007  Cathepsin L2 inhibitor
0,153  0,058  Alkaline phosphatase inhibitor
0,163  0,069  Eye irritation, high
0,115  0,023  Keratolytic
0,136  0,046  Carcinogenic, group 2B
0,183  0,092  Insulin sensitizer
0,135  0,047  Glutathione S-transferase substrate
0,104  0,016  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,114  0,026  Bile acid receptor antagonist
0,117  0,030  NAD(P)H dehydrogenase (quinone) inhibitor
0,170  0,084  Antirickettsial
0,202  0,119  Immunostimulant
0,107  0,024  Peroxisome proliferator-activated receptor gamma agonist
0,153  0,070  Acaricide
0,143  0,061  Ca2+-transporting ATPase inhibitor
0,114  0,033  Antiviral (Rhinovirus)
0,123  0,043  Sulfotransferase substrate
0,207  0,128  Antidiabetic (type 2)
0,142  0,064  Psychosexual dysfunction treatment
0,103  0,026  CDC25A inhibitor
0,185  0,108  Antineoplastic (lymphoma)
0,118  0,042  Creatine kinase inhibitor
0,087  0,012  Transcription factor RelA inhibitor
0,120  0,045  DOPA decarboxylase inhibitor
0,131  0,056  Beta amyloid protein antagonist
0,148  0,074  Antiviral (Influenza A)
0,127  0,054  Microtubule formation inhibitor
0,112  0,042  UGT2B11 substrate
0,122  0,052  Mucolytic
0,084  0,014  Estrogen receptor beta agonist
0,096  0,027  SULT1A2 substrate
0,107  0,038  Alpha 2d adrenoreceptor antagonist
0,076  0,009  Pregnane X receptor antagonist
0,079  0,011  Glucose-6-phosphate translocase inhibitor
0,175  0,108  Angiogenesis stimulant
0,143  0,076  Cyclooxygenase inhibitor
0,095  0,029  Leukotriene synthesis inhibitor
0,094  0,028  HIV-1 integrase inhibitor
0,140  0,075  Protein kinase stimulant
0,170  0,106  Cardiodepressant
0,090  0,027  HIV-1 integrase (Strand Transfer) inhibitor
0,133  0,070  Antiacne
0,115  0,053  AMP-activated protein kinase stimulant
0,151  0,089  Mcl-1 antagonist
0,104  0,042  Actinic keratosis treatment
0,156  0,095  Phospholipase C inhibitor
0,130  0,071  Tubulin antagonist
0,121  0,063  Alcohol dehydrogenase substrate
0,232  0,174  Antineoplastic (small cell lung cancer)
0,155  0,099  Diabetic nephropathy treatment
0,140  0,085  Cholinergic
0,106  0,054  Anabolic
0,159  0,107  Pyruvate kinase inhibitor
0,186  0,134  5 Hydroxytryptamine release stimulant
0,144  0,093  Prostatic (benign) hyperplasia treatment
0,061  0,011  Retinoid X alpha receptor agonist
0,069  0,020  Leukotriene B4 antagonist
0,080  0,032  Leukotriene antagonist
0,089  0,042  Phosphodiesterase 4D inhibitor
0,060  0,014  Retinoid X receptor agonist
0,124  0,078  NADPH oxidase inhibitor
0,054  0,009  Retinoid X receptor antagonist
0,216  0,172  FMO1 substrate
0,085  0,042  Antibiotic
0,047  0,005  Inosine monophosphate dehydrogenase 1 inhibitor
0,165  0,128  VEGF expression inhibitor
0,105  0,068  Choleretic
0,103  0,067  UGT2B1 substrate
0,046  0,009  Retinoid X alpha receptor antagonist
0,044  0,008  Estrogen-related receptor beta antagonist
0,165  0,129  Cyclic AMP phosphodiesterase inhibitor
0,133  0,099  GABA C receptor rho-2 antagonist
0,062  0,028  Acetyl-CoA transferase 2 inhibitor
0,120  0,086  Antineoplastic (uterine cancer)
0,129  0,096  Diuretic
0,078  0,045  Phosphodiesterase VI inhibitor
0,062  0,031  Aldose reductase inhibitor
0,100  0,069  Expectorant
0,130  0,101  Adenylate cyclase stimulant
0,137  0,107  Prostate disorders treatment
0,065  0,036  Androgen agonist
0,046  0,017  Retinoic acid alpha receptor agonist
0,059  0,031  Dihydroorotate oxidase inhibitor
0,059  0,032  Leukotriene C antagonist
0,046  0,020  5-Alpha-reductase inhibitor
0,074  0,049  Telomerase inhibitor
0,082  0,058  Antiprotozoal activity enhancer
0,082  0,059  Inducible nitric-oxide synthase inhibitor
0,051  0,028  Potassium channel Kv1.3 blocker
0,057  0,038  Postcoital contraceptive
0,116  0,098  Vanilloid 1 agonist
0,074  0,058  Antitreponemal
0,114  0,099  Antiprotozoal (Trichomonas)
0,037  0,022  Estrogen receptor alpha agonist
0,107  0,093  Cyclooxygenase 3 inhibitor
0,166  0,155  Antiprotozoal (Trypanosoma)
0,069  0,059  Carbonic anhydrase XIII inhibitor
0,029  0,019  Leukotriene B4 receptor 1 antagonist
0,046  0,036  Cholesterol esterase inhibitor
0,058  0,050  Antimycoplasmal
0,090  0,082  Antifungal (Candida)
0,084  0,077  Butyrylcholinesterase inhibitor
0,083  0,077  Uric acid excretion stimulant
0,105  0,098  Cyclooxygenase 2 inhibitor
0,049  0,043  Vanilloid 2 antagonist
0,022  0,016  Leukotriene B4 receptor 2 antagonist
0,058  0,052  Heme oxygenase stimulant
0,028  0,025  Squalene synthetase inhibitor
0,135  0,134  Antiviral (Influenza)

